Venture capital investment in US biopharmaceutical companies slowed in early July as Americans dealt with the awkwardness of celebrating a national holiday right in the middle of the work week by taking the whole week off, allowing counterparts in Asia and Europe to enjoy the new funding spotlight.
While the US eased into Fourth of July week by temporarily turning off the public relations machines that promote new VC financings, the PR didn't slow for companies focused on or operating from Asia and Europe